Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Interleukin 7 Receptor Subunit Alpha (CDw127 or CD127 or IL7R) - Overview
Interleukin 7 Receptor Subunit Alpha (CDw127 or CD127 or IL7R) - Therapeutics Development
Products under Development by Stage of Development
Products under Development by Therapy Area
Products under Development by Indication
Products under Development by Companies
Interleukin 7 Receptor Subunit Alpha (CDw127 or CD127 or IL7R) - Therapeutics Assessment
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Interleukin 7 Receptor Subunit Alpha (CDw127 or CD127 or IL7R) - Companies Involved in Therapeutics Development
Allterum Therapeutics LLC
Genexine Inc
Medikine Inc
OSE Immunotherapeutics SA
RevImmune SAS
Zura Bio Ltd
Interleukin 7 Receptor Subunit Alpha (CDw127 or CD127 or IL7R) - Drug Profiles
CYT-107 - Drug Profile
Product Description
Mechanism Of Action
History of Events
efineptakin alfa - Drug Profile
Product Description
Mechanism Of Action
History of Events
lusvertikimab - Drug Profile
Product Description
Mechanism Of Action
History of Events
MDK-701 - Drug Profile
Product Description
Mechanism Of Action
History of Events
Monoclol Antibody to Antagonize IL7R for Acute Lymphocytic Leukemia - Drug Profile
Product Description
Mechanism Of Action
History of Events
OSE-703 - Drug Profile
Product Description
Mechanism Of Action
History of Events
ZB-168 - Drug Profile
Product Description
Mechanism Of Action
History of Events
Interleukin 7 Receptor Subunit Alpha (CDw127 or CD127 or IL7R) - Dormant Products
Interleukin 7 Receptor Subunit Alpha (CDw127 or CD127 or IL7R) - Discontinued Products
Interleukin 7 Receptor Subunit Alpha (CDw127 or CD127 or IL7R) - Product Development Milestones
Featured News & Press Releases
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures

List of Figures
Number of Products under Development by Stage of Development, 2022
Number of Products under Development by Therapy Areas, 2022
Number of Products under Development by Top 10 Indications, 2022
Number of Products by Mechanism of Actions, 2022
Number of Products by Stage and Mechanism of Actions, 2022
Number of Products by Top 10 Routes of Administration, 2022
Number of Products by Stage and Top 10 Routes of Administration, 2022
Number of Products by Top 10 Molecule Types, 2022
Number of Products by Stage and Top 10 Molecule Types, 2022

List of Tables

List of Tables
Number of Products under Development by Stage of Development, 2022
Number of Products under Development by Therapy Areas, 2022
Number of Products under Development by Indications, 2022
Number of Products under Development by Indications, 2022 (Contd..1)
Number of Products under Development by Indications, 2022 (Contd..2)
Number of Products under Development by Companies, 2022
Products under Development by Companies, 2022
Products under Development by Companies, 2022 (Contd..1)
Products under Development by Companies, 2022 (Contd..2)
Products under Development by Companies, 2022 (Contd..3)
Number of Products by Stage and Mechanism of Actions, 2022
Number of Products by Stage and Route of Administration, 2022
Number of Products by Stage and Molecule Type, 2022
Pipeline by Allterum Therapeutics LLC, 2022
Pipeline by Genexine Inc, 2022
Pipeline by Medikine Inc, 2022
Pipeline by OSE Immunotherapeutics SA, 2022
Pipeline by RevImmune SAS, 2022
Pipeline by Zura Bio Ltd, 2022
Dormant Products, 2022
Dormant Products, 2022 (Contd..1)
Discontinued Products, 2022